IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...
Following a careful review of the final proposals received in connection with the potential transaction, the Committee has concluded that none of the final proposals is adequate and in the best ...
InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...
InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...
YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will ...
As of April 24, 2023, the average one-year price target for Inmode is 47.53. The forecasts range from a low of 40.40 to a high of $55.65. The average price target represents an increase of 41.00% from ...
The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results